ID

20229

Descrizione

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one.

Keywords

versioni (2)
  1. 15/02/17 15/02/17 -
  2. 20/02/17 20/02/17 -
Caricato su

15 febbraio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Inglese

Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 moduli  
Toast Criteria
Descrizione

Toast Criteria

1. For the qualifying stroke, please categories the ethnologic below (indicate one only)
Descrizione

Etiologic subtype

Tipo di dati

integer

Concomitant Medication
Descrizione

Concomitant Medication

Alias
UMLS CUI-1
C2347852
2. Are any medications listed below currently being taken on the day of visit 1?
Descrizione

Medication taken

Tipo di dati

boolean

If yes, please indicate which, if any, of the following are currently being taken:
Descrizione

If the patient is taking any restricted (bolded) concomitant medications (see facing page), please ensure these are stopped prior to randomasation.

Tipo di dati

integer

ACE Inhibitors
Descrizione

ACE Inhibitors

Alias
UMLS CUI-1
C0003015
3. Are ACE Inhibitors currently being taken on the day of visit 1?
Descrizione

ACE Inhibitors currently taken

Tipo di dati

boolean

Name of ACE Inhibitor and Total Daily Dose
Descrizione

Name of ACE Inhibitor and Total Daily Dose

Tipo di dati

text

Ritorna all'inizio della pagina

Similar models

Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Toast Criteria
Item
1. For the qualifying stroke, please categories the ethnologic below (indicate one only)
integer
Etiologic subtype
Code List
1. For the qualifying stroke, please categories the ethnologic below (indicate one only)
CL Item
Large-artery atherosclerosis (1)
CL Item
Cardioembolism (2)
CL Item
Small-artery occlusion (lacune) (3)
CL Item
Acute stroke of other determined etiology (4)
CL Item
Stroke of underdetermined etiology (5)
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Medication taken
Item
2. Are any medications listed below currently being taken on the day of visit 1?
boolean
Item
If yes, please indicate which, if any, of the following are currently being taken:
integer
If yes, please indicate which
Code List
If yes, please indicate which, if any, of the following are currently being taken:
CL Item
Dipyridamole (0)
CL Item
Aspirin (1)
CL Item
Ticlopidine (2)
CL Item
Clopidogrel (3)
CL Item
Aspirin/extended release Dipyridamole (4)
CL Item
Oral anticoagulants (5)
CL Item
Nitrates (oral or topical) (6)
CL Item
Estrogen replacement without progesterone (7)
CL Item
Estrogen replacement with progesterone (8)
CL Item
Digitalis (9)
CL Item
Statins (10)
CL Item
Fibrates (11)
CL Item
Dilitazem/Verapamil (12)
CL Item
Other calcium channel blockers (13)
CL Item
Alpha-blocker (14)
CL Item
Direct vasodilators (15)
CL Item
Angiotensin Receptor Blocker (ARB) (16)
CL Item
Peripheral sympatholytic (17)
CL Item
Central sympatholytic (18)
CL Item
Alpha-beta blocker (19)
CL Item
Beta-blocker (20)
CL Item
Loop-active diuretics (21)
CL Item
Diuretics of thiazide type (22)
CL Item
Potassium-sparing diuretics (23)
CL Item
Insulin (24)
CL Item
Oral hypoglycemic agents (25)
CL Item
Non-steroidal anti-inflammatory drugs (26)
CL Item
Specific Cox II inhibitors (27)
Item Group
ACE Inhibitors
C0003015 (UMLS CUI-1)
ACE Inhibitors currently taken
Item
3. Are ACE Inhibitors currently being taken on the day of visit 1?
boolean
Name of ACE Inhibitor and Total Daily Dose
Item
Name of ACE Inhibitor and Total Daily Dose
text
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial